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Background: Breathlessness is the most common symptom limiting exercise in patients with 
chronic obstructive pulmonary disease (COPD). Exercise training can improve both exercise 
tolerance and health status in these patients, intensity of exercise being of key importance. 
Nevertheless, in these patients extreme breathlessness and/or peripheral muscle fatigue may 
prevent patients from reaching higher levels of intensity.
Study objective: This study was to determine whether inspiratory pressure support (IPS) 
applied during sub maximal exercise could enable individuals with severe but stable COPD to 
increase their exercise tolerance.
Participants: Twelve subjects with severe stable COPD (mean (SD): age = 63(8.2) years; 
FEV1 = 0.89(0.42) L (34)% predicted; FEV1/FVC = 0.31(0.07) only nine subjects completed 
the study.
Intervention: Each subject completed ten sessions of cycling at 25%–50% of their maximum 
power without NIVS and another ten sessions using NIVS.
Measurements and results: Dyspnea was measured using Borg scale. Subjects reached high 
levels of dyspnea 4.7 (1.81) during the sessions without NIVS vs low levels of dyspnea during 
the sessions using NIVS 1.3 (0.6). Exercise time during the sessions without NIVS and with 
NIVS was 19.37 (3.4) and 33.75 (9.5) min, respectively. Maximal workload during the sessions 
without NIVS and with NIVS was 27 (3.7) and 50 (10.5) watt, respectively.
Conclusion: We conclude that IPS delivered by nasal mask can improve exercise tolerance 
and dyspnea in stable severe COPD patients and hence this mode of ventilatory support may 
be useful in respiratory rehabilitation programs.
Keywords: noninvasive ventilation pressure support, COPD, exercise, pulmonary rehabilita-
tion, dyspnea
Introduction
In patients with chronic obstructive pulmonary disease (COPD), exercise limitation is 
a major symptom (Killian et al 1992). Reduced ventilatory capacity combined with an 
increased ventilatory load leads to intolerable dyspnea at low level of exercise (Belman 
1992). Avoidance of dyspnea and, hence, exercise produces progressive decondition-
ing in lower limb muscles indicated by reduced capillary density, mitochondria, and 
oxidative enzymes (Maltais et al 1999).
Exercise training as a part of multidisciplinary pulmonary rehabilitation can improve 
both exercise tolerance and health-related quality of life in patients with chronic obstructive 
pulmonary disease (COPD) (Toosters et al 2005). The following physiological changes 
contributing to these improvements were: reduction of lactic acidosis; minute ventilation 
and heart rate for a given work rate; and enhanced activity of mitochondrial enzymes and 
capillary density in the trained muscles. Intensity of exercise training is of key importance. 
High-intensity training has improved both maximal and sub-maximal exercise tests and International Journal of COPD 2007:2(4) 586
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has induced both cardio-respiratory and peripheral muscle 
adaptations (Casaburi et al 1991). However, patients with 
severe COPD are unable to exercise sufﬁ  ciently to produce a 
true physiological training effect because of ventilatory limita-
tion (Casaburi et al 1997).
Noninvasive mechanical ventilation, administered in the 
form of continuous positive pressure ventilation or pressure 
support ventilation (bi-level positive airway pressure or 
proportional assisted ventilation), unload the respiratory 
muscles (Mehta and Hill 2001). However, noninvasive 
mechanical ventilation has therefore found use during severe 
exacerbations of COPD (Lightowler et al 2003) and hypoxic 
respiratory failure (Ferrer et al 2003). It also has been shown 
to improve dyspnea and exercise endurance in patients with 
COPD (Maltais et al 1995; Van’t Hul et al 2004). Using 
inspiratory support, the load in the inspiratory muscles is 
reduced, with a consequent reduction in the work of breathing 
(Maltais et al 1995). Blood gases improve (Babcock et al 
2002) and patients are able to sustain lactic acid accumula-
tion for longer periods of time (Keilty et al 1994). Hence, 
the application of inspiratory support, through proportional 
assisted ventilation, or continuous positive airway pres-
sure ventilation may potentially lead to enhanced training 
intensity.
Proportional assisted ventilation (PAV), a mode of venti-
lation that matches ventilator output to patient effort (Younes 
1992), is more tolerable for patients with COPD (Stell et al 
2000) and is as effective at prolonging exercise.
We hypothesized that in patients with COPD, training 
using inspiratory support through proportional assisted 
ventilation would lead to an improvement in exercise 
tolerance, dyspnea, and would prolong the period of training, 
through its decrease of the ventilatory requirement.
Methods
Patients gave their informed consent to participate into the 
study which was approved by our local institutional review 
board.
Patients
A total of twelve patients (10 males, 2 females) with severe 
COPD (based on history, clinical, chest radiology, and 
physiologic evidence) who were clinically stable were included 
in the study. COPD was deﬁ  ned according to American 
Thoracic Society (ATS) criteria (American Thoracic Society 
1987). Patients with overt cardiovascular or musculoskeletal 
disease, other organ failure, cancer and inability to co-operate 
were excluded from the study. Only nine patients completed 
the study. Reasons for not completing the study included 
exacerbation of underlying disease (one patient with a problem 
of a trial ﬁ  brillation), noncompliance with the ventilator (one 
patient) and long pulmonary hospitalization (one patient).
At the time of the study, the patients had been free from 
exacerbations for at least 2 months. All of the patients were 
on long-term oxygen therapy; two patients were on long-term 
home mechanical ventilation (MV). Demographic and func-
tional characteristics of patients are shown in Table 1.
Exercise regimen
Patients participated in a program of exercise on a calibrated 
cycle ergo meter. Twenty exercise sessions were held two 
to three times per week for about 8 weeks or 20 sessions, 
the ﬁ  rst ten sessions were without NIV (unsupported ses-
sions) and the last ones were with NIV (supported ses-
sions). Exercise duration was 25 minutes for the ﬁ  rst ten 
sessions, although initially many patients were unable to 
cycle continuously for this length of time, and the exercise 
duration was 30 minutes for the last ten sessions, and we 
encouraged the patients to increase this duration as much 
as they could. Each session was observed by one of the 
authors who vigorously encouraged the patients to reach 
the intensity and the duration targets. Initial intensity 
targets were set at 10 watts for all patients, this work was 
increased progressively during the ﬁ  rst 5 sessions in order 
to reach the rate of 70% of the peak work rate observed in 
the incremental maximal exercise test.
This was achieved by increasing the work rate by 5 watts 
once the subject was able to maintain the existing work 
rate for 25 minutes. In patients who were unable to cycle 
continuously at the initial work rate, short rest periods were 
allowed. Breathlessness and leg fatigue were assessed during 
training sessions using Borg score (Borg 1982). Patients were 
Table 1 Baseline characteristics of patients
Subject characteristics 
Patients n  12
Age years  63.3(8.2)
Sex female/male  2/10
Smokers/nonsmokers 8/4
Body-mass index (kg/m²)  22.3(2.6)
Lung function 
FEV1 L  0.89(0.42)
FVC L  2.86(0.56)
FEV1/FVC 0.31(0.07)
RV L  3.28(1.18)
Abbreviations: FEV1, forced expiratory volume in one second; FVC, forced vital 
capacity; RV, residual volume.
Data are presented as mean ± SD.International Journal of COPD 2007:2(4) 587
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strongly encouraged not to stop until a symptom rating of 5 
(severe) or more was achieved.
During the exercise sessions, heart rate and arterial oxy-
gen saturation, measured by pulse oximetry, were recorded 
continuously. For patients requiring supplemental oxygen, 
oxygen was delivered by nasal cannulae during the sessions 
without NIV and by the ventilator during the sessions with 
NIV, the oxygen was delivered at a sufﬁ  cient rate to keep 
the ﬁ  ngertip oxygen saturation at 92% or above.
Ventilatory assistance was delivered using a AI or 
AIVT visions in PAV mode (VS Ultra) applied via a tightly 
ﬁ  tting nasal mask (type Fisher and Paykel “ACLAIM”). 
The ventilator settings were individually chosen prior to the 
program to maximize patient comfort; typically the trigger 
was as sensitive as possible. At the beginning of the session, 
patients were instructed to breathe quietly on the bicycle 
without pedaling for ~5 min to become accustomed to the 
breathing circuit. In the last 2 min of this adaptation, quiet 
breathing data were recorded, therefore the parameters of 
the ventilation were: the inspiratory support ranged from 
14 to 17, the expiratory pressure from 3 to 4 cm H2O, the 
minimal respiratory frequency from 5 to 12 per minute, the 
trigger pressure from 4 to 6 cm H2O, the inspiratory time 
was 25% of the ventilatory cycle, the minimal inspiratory 
time was 1.4, the maximal inspiratory time was 2.7 and the 
slope ranged from 2 to 3.
Measurements
Patients visited the laboratory on two occasions before and 
two occasions within one week of ﬁ  nishing the program. 
Testing sessions were performed at the same time of day for 
each individual patient.
Spirometric tests
Spirometric tests were performed using a pneumocheck(R) 
Spirometer (ms medi-soft module 5500, USA), and all pro-
cedures were carried out according to ATS guidelines. The 
parameters evaluated were: forced vital capacity (FVC), 
forced expiratory volume (FEV1), Tiffenau index (FEV1/
FVC) ratio, and a plethysmography (medi-soft) for residual 
volume (RV) measurements.
Quality of life
Health status was assessed using the St. George’s Respiratory 
Questionnaire (SGRQ), which is a self-report questionnaire 
and scores health status in three areas: symptoms (dyspnea, 
wheezing, and coughing), activity (the severity to which 
activities of daily living are impaired by dyspnea), and 
impacts (the inﬂ  uence of respiratory symptoms on social 
participation) (Jones et al 1992).
Walking test
Each patient was submitted to a 6-minute walking test 
(6MWT), conducted in a closed corridor of 30 meters. 
Each test was given twice, with a 10–15 minute interval 
between the two. During the test the patient was instructed 
to walk as fast as possible for six minutes and to decrease 
speed or interrupt the test if experiencing severe dyspnea or 
any other limiting discomfort. The examiner gave patients 
verbal encouragement once per minute using standard moti-
vational phrases intended to ensure that patients walked as 
fast as possible throughout the test. Heart rate, dyspnea, and 
partial oxygen saturation were measured before and after 
each test. A trained investigator who did not have access 
to previous evaluations applied the test or information on 
the group the patient belonged to.
Statistical analysis
All values are presented as mean ± SD. Comparisons between 
responses before and after the training program were made 
using paired Student’s t-tests. Comparisons between the two 
groups (with and without NIV) were made using unpaired 
t-tests. Mean values are reported with 95% confidence 
intervals (95%CI).
The strength of association between variables was tested 
using the Mann-Whitney/Wilcoxon Two-Sample Test. 
Signiﬁ  cance was accepted at the p < 0.05 level.
Results
Subjects
Twelve subjects were screened for the study. Three were 
excluded, as they were unable to complete the program of 
rehabilitation with noninvasive ventilation. Nine subjects 
(two female), with a mean age of 63.3 ± 8.2 yrs, completed 
the protocol. The demographic details are given in Table 1. 
The mean FEV1 was 0.89 ± 0.42 L (34% pred). The mean 
FEV1/FVC ratio was 0.31 ± 0.07% of the predicted value. 
The mean residual volume was 3.28 ± 1.18 L (153% pred). 
Two subjects were already using nocturnal home ventilation 
and one subject was using nocturnal continuous positive 
airway pressure (CPAP) via nasal mask for obstructive 
sleep apnea.
Quality-of-life measures
Baseline and after rehabilitation SGRQ scores are given in 
Table 2.International Journal of COPD 2007:2(4) 588
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SGRQ scores
Table 2 shows the results of the SGRQ. For the supported 
sessions, there were significant improvements (with a 
decrease of more than 4 for the score) in symptom, activity 
and total scores but worsening of the impact score. For the 
unsupported sessions, there was worsening for all scores.
Walking distance
All patients had a shorter 6-min mean distance at study entry 
compared with that at the end of the study, and this improve-
ment of the distance walked was statistically signiﬁ  cant. 
There was a mean increase of the distance walked of 37.5 m 
at the end of the study for the supported sessions and only an 
improvement of 14 m for the unsupported ones, which was 
also lower than the signiﬁ  cant clinical difference (more than 
54 m (Redelmeier et al 1997)) as noted in Table 3.
Exercise physiology
Session duration, dyspnea and maximal workload for the 
supported sessions and for the unsupported sessions are 
noted in Table 3.
All subjects exercised longer while using the ventila-
tion; mean session duration increased from 19.37 ± 3.4min-
utes at the end of the unsupported sessions to 33.75 ± 9.5 
minutes at the end of the supported ones. The comparison 
between the supported with the unsupported session 
duration was statistically signiﬁ  cant (p < 0.05); session 
duration was limited with dyspnea for the unsupported 
sessions whereas it was limited by the subjects voluntary 
for the supported sessions; the increase in exercise duration 
was not associated with any adverse symptoms or morbid 
changes in the ECG.
We noticed also a signiﬁ  cant improvement (p < 0.05) in 
the level of post-effort dyspnea (measured at the end of each 
session) for the supported sessions from 4.7 ± 1.81 to 1.3 ± 
0.6 using Borg score, whereas this improvement was lower 
for the unsupported sessions (from 6 ± 2.6 to 4.7 ± 1.81).
By the end of the twenty training sessions, the patients (of 
the supported sessions) showed an improved Wmax (p < 0.05) 
of 90 % ( from 27 to 50), whereas the same patients (but after 
the unsupported sessions) were not able to improve their Wmax 
more than 25% (from 20 to 27), as noted in Table 3.
Discussion
In severe COPD patients, the respiratory muscle strength and 
endurance are often reduced which can lead to the develop-
ment of a respiratory muscle fatigue and contribute to the 
poor exercise tolerance. Although some studies have dem-
onstrated an individual beneﬁ  t of respiratory muscle training 
on overall exercise tolerance (Lisboa et al 1997), the actual 
efﬁ  cacy of such a training program has been contested (Smith 
et al 1992). The increase in minute ventilation performed 
during lower limb exercise could achieve a similar level 
of respiratory muscle training (Sergysels 1996). However, 
in patients exhibiting dyspnea and CO2 retention at lower 
intensities of exercise, the training load is often much reduced 
(limited to unloaded cycling). In our study, we demonstrated 
the feasibility and the beneﬁ  t on the ventilatory adaptation 
with training of the application of a ventilatory support dur-
ing every exercise session.
The results of this study show that, in stable patients 
with severe COPD, short term, noninvasive application of 
IPS during exercise sessions of an outpatient program of 
rehabilitation: (1) improves the quality of life, (2) improves 
the exercise tolerance, (3) augments the period of exercise 
and (4) decreases the sensation of breathlessness during the 
exercise.
The cornerstone of respiratory rehabilitation is exercise 
training. Other modalities such as education and psychosocial 
support may be useful as an adjuncts to exercise training but 
by themselves are unlikely to inﬂ  uence exercise tolerance or 
health-related quality of life (Ries et al 1995; Sassi-Dombron 
et al 1995). The magnitude of the physiologic training 
effect is strongly inﬂ  uenced by the intensity of the exercise 
Table 2 Change in St. George’s respiratory questionnaire score among patients with chronic obstructive pulmonary disease 
who received pulmonary rehabilitation(unsupported and supported) by NIV
  St. George’s respiratory questionnaire     
  Unsupported sessions    Supported sessions
  Baseline   After 10 sessions  Baseline   After 10 sessions
Symptoms* 51.57(19)  54.57(20)  54.57(20)  48.44(21)
Activities* 76.54(16)  79.74(15)  79.74(15) 74.83(12)
Impact   62.97(13)  64.5(16)  64.50(16)  66.05(22)
Total* 60.69(10)  63.71(12)  63.71(12)  58.39(17)
Data are presented as mean+/-SD.
*signiﬁ  cant changes for the supported sessions with a decrease of each score of more than 4.International Journal of COPD 2007:2(4) 589
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(Casaburi et al 1991). However, many subjects with COPD 
are unable to tolerate high workloads because they are limited 
by severe dyspnea.
Several studies have examined the acute effects of 
different modalities of ventilatory assistance on dyspnea 
and exercise tolerance in advanced COPD. The message 
of these physiological studies could be summarized as 
follows: assisted ventilation delivered as noninvasive 
positive pressure ventilation (NPPV), either as continuous 
positive airway pressure (CPAP), or inspiratory pressure 
support (IPS) or proportional assisted ventilation (PAV), 
during exercise reduces dyspnea and work of breathing and 
enhances exercise tolerance in COPD patients (Ambrosino 
and Strambi 2004).
To date, five randomized, controlled studies have 
compared the effects of training with NIVS to unsupported 
training in patients with COPD. Johnson et al (2002) and Van 
′t Hul et al (2006) found a signiﬁ  cant between-group differ-
ence in the gain in walking endurance in favor of the group 
training with NIVS. In contrast, two studies (Hawkins et al 
2002; Costes et al 2003) reported a between-group difference 
in the maximal incremental cycle exercise test in favor of 
patients training with NIVS, but not for the constant work rate 
cycle endurance test. Bianchi et al (2002) observed no differ-
ential effect of training with NIVS on exercised performance 
or health status. Finally, Van’t Hul et al (2006) have evalu-
ated the effects of training with mask IPS in COPD patients. 
They compared 10 cm H2O IPS with 5 cm H2O IPS delivered 
during high-intensity training. IPS10 resulted in signiﬁ  cantly 
larger improvements in exercise performance than training 
with IPS5; the authors of this article have done their best to 
demonstrate the effectiveness of NPPV as an aid to exercise 
training in COPD patients. The ﬁ  rst four studies, apart from 
having different outcomes, suffer from considerable meth-
odological limitations. First, observers were not blinded to 
treatment allocation in any of these studies. Secondly, none 
incorporated a “sham” type of NIVS, contrasting the effects 
of training. Consequently, a placebo effect of NIVS could not 
be ruled out to explain the differences in effect. Nevertheless, 
the last study (Van’t Hul et al 2006) raises some concerns 
and does not solve the problems regarding the practical use 
in a routine setting.
As we know, IPS is a form of mechanical ventilation 
when applied noninvasively to patients in acute and chronic 
respiratory failure. It is a pressure-targeted mode in which 
each breath is patient-triggered and supported (Brochard 
1994). It provides breath-by-breath ventilatory support by 
means of a positive-pressure wave that is synchronized 
with the inspiratory effort of the patient. During inspiration, 
the airway pressure is raised to a pre-set level: the pressure 
support level. This level is maintained until the machine 
determines the end of a patient’s respiratory effort or detects 
a patient’s demand for expiration. The diaphragmatic work, 
as assessed by the transdiaphragmatic pressure, was reduced 
during exercise with IPS which conﬁ  rms its physiological 
effect on exercise tolerance (Maltais et al 1995).
In addition, it was clear from numerous studies, that 
application of NPPV unloads the inspiratory muscles during 
exercise. Younes et al (1992) showed that in normal subjects 
undergoing heavy exercise, PAV reduced the esophageal 
pressure (Poes) swings giving a sensation of easier breathing. 
Although experimental data are lacking, it seems reasonable 
to hypothesize a similar mechanism to explain the improve-
ment in exercise tolerance in severe COPD.
On the other hand, it has been shown that PSV reduces 
the diaphragmatic pressure-time product (Ptp, di), dyspnea 
(Kyroussis et al 1996), and slows down the maximum relax-
ation rate of inspiratory muscles.
In our study, 3 patients were not able to comply with 
the rehabilitation program, which was sometimes because 
of the difﬁ  culty of the patient’s adaptation to the requests of 
the ventilation, and on the other hand, the low number of our 
group was also because of the difﬁ  culty to persuade most of 
the COPD patients to participate in such a program.
Table 3 Changes in the walked distance within 6MWT, post-effort dyspnea, session duration and the maximal workload during 
the incremental maximal exercise test
6MWT, Session duration, post-effort dyspnea, maximal workload
  Unsupported sessions  Supported sessions 
  Baseline  After 10 sessions  Baseline   After 10 sessions  p
Walking distance of 6 MWT (m)  231(97)  245(87)  245(87)  282(111)  <0.01§
Session duration (minute)  9(4.2)  19.37(3.4)  19.37(3.4)  33.75(9.5)  0.039§
Dyspnea (Borg scale)  6(2.6)  4.7(1.81)  4.7(1.81)  1.3(0.6)  <0.01§
Wmax (watts)  20(5)  27(3.7)  27(3.7)  50(10.5)  0.043§
Data are presented as mean ± SD.
§: p < 0.05, unpaired t-test between the changes in both groups of sessions.International Journal of COPD 2007:2(4) 590
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Our group of patients was well matched with respect to 
lung function and age, but there were only two women (14%) 
in the group which was due to the decreased females diagnosed 
with COPD compared with this diagnosis among males.
As for the effects of training on health status, there were 
signiﬁ  cantly lower scores in the activity, symptom and total 
components of the SGRQ and lower scores but not signiﬁ  -
cantly for the impact component. An improvement of more 
than 4% in total score (expressed as a percentage of maximum 
score) is considered to be clinically relevant (Schunemann 
et al 2003). Thus the improvement of total score for supported 
patients of 4.68 was clinically relevant.
An improvement in the parameters of the exercise 
tolerance was noted at the end of the supported sessions, 
which was clear by the increase of the distance walked dur-
ing the 6 MWT of 37 m, this increase was lower than the 
signiﬁ  cant clinical increase (54 m, Redelmeier et al 1997). 
This lack of signiﬁ  cance was probably due to the small 
number of subjects in the actual study.
Finally, a notable decrease in the post-effort dyspnea was 
noted during the supported sessions and also an increase in 
the duration of the supported sessions which were statistically 
signiﬁ  cant.
The mean ﬁ  ndings of our present study are that patients 
with severe COPD who received ventilatory assistance during 
an exercise program achieved greater training intensities, 
longer exercise duration and with less dyspnea after this 
exercise.
The mean effect of the ventilatory assistance was to 
increase the training intensity tolerated during the period 
of application of NIVS, which was apparent from the third 
session of the ten supported sessions, and maintained to the 
end of the program, as we could not increase the work load 
for our patients within the ﬁ  rst unsupported ten sessions more 
than 25–30 watts.
A limitation of our study is the lack of blindness of the 
researchers to the treatment allocation which is also true for 
most other “positive” studies, and therefore the subjects were 
not blinded to the intervention that they received and the use 
of mask ventilation can produce a signiﬁ  cant placebo effect. 
However, there is no convincing way of blinding subjects 
to this intervention.
Although the results of this study could, in part, possibly 
be explained by a placebo effect of the application of IPS, 
allowing the patient to achieve greater training intensities, 
as well as all the fact that all subjects received the same 
encouragement and support, we doubt that this is an impor-
tant factor, given that the improvements noted within the 
parameters of the exercise tolerance during the supported 
sessions were very large especially for the session duration 
and the post-effort dyspnea during these sessions.
The small number of subjects that were recruited in our 
study is another limitation, as for most other studies which deal 
with NIVS as an aid to exercise training in COPD patients, and 
therefore had a limited power to conﬁ  rm our ﬁ  ndings.
The application of NIVS by a nasal mask gave also some 
difﬁ  culties to our patients, in that nasal breathing is common 
at rest but oronasal breathing appears to be universal during 
exercise. This made some difﬁ  culties for our patients espe-
cially at the ﬁ  rst period of our protocol, because they had to 
use only nasal breathing during our protocol of NIVS.
Conclusion
The mode of ventilation (Inspiratory pressure support (IPS)) 
delivered by a nasal mask was able to improve exercise 
tolerance and reduce dyspnea in severe stable chronic 
obstructive pulmonary disease patients. Further investiga-
tions are needed to elucidate the appropriate application of 
NIVS in respiratory rehabilitation programs.
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